This site is intended for US Healthcare Professionals Only
The program can collectively award a total of up to US$1 million in grants. The research project duration can extend over two years.
The PHAB Awards aim to support clinical research in pulmonary hypertension (PH) with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Applicants may include early-mid career investigators, fellows in training, and other PH healthcare professionals working in the USA. The objectives of the program are to:
- Support continued advancement in PH science and care
- Contribute to the continued growth of early-career scientists and clinicians involved in PH research
